Sirio Pharma Co., Ltd. (hereinafter referred to as "SIRIO"), founded in 1993, is dedicated to providing customers in the global nutraceutical industry with full-chain solutions, encompassing basic research, product development, manufacturing, packaging, logistics, and marketing support. On September 25, 2019, the company was listed on the ChiNext board of the Shenzhen Stock Exchange (stock code: 300791.SZ), marking it as the first CDMO in nutritional supplements to be listed on A-shares in China.